Prelude Therapeutics Inc

NASDAQ:PRLD

0.81

-0.07 (-8.16%)

4:32:27 PM EDT: $0.81 0.00 (-0.58%)

Prelude Therapeutics Inc Stock, NASDAQ:PRLD

175 Innovation Boulevard, Wilmington, Delaware 19805

United States of America

Phone: +1.302.467.1280

Number of Employees: 131

http://www.preludetx.com

Description

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.